Literature DB >> 8033134

Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen.

S gata1, A Chen, S H Itzkowitz.   

Abstract

Sialosyl-Tn (STn) is a mucin-associated carbohydrate antigen that is not expressed by most normal epithelial cells but becomes expressed in several types of adenocarcinomas, where it is often associated with a poor prognosis. Little is known about the regulation of the STn phenotype in tumor cells and the immune response to STn antigen. In the present study, we established clonal cell lines in which virtually all of the cells were STn positive (designated LS-C) or STn negative (designated LS-B). These two cell lines, derived from a single parental cell line, LS174T, have the same total protein electrophoretic profiles but carry markedly different oligosaccharide structures on their mucin; the mucin from LS-C cells has only the Tn and STn structures, whereas LS-B cell mucin lacks these simple structures but carries more complex oligosaccharides. These results indicate that lack of STn expression by cells can be due to the lack of STn synthesis rather than inaccessibility of antibodies to bind to STn by steric hindrance. Both clones were similar in their growth rates, response to gamma-interferon, and sensitivity to lysis by lymphokine-activated killer cells. These cells may be important models for understanding the regulation of glycosylation at the cellular level and for further studies of tumor biology and immune response to STn antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033134

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  A rat experimental model for the design of vaccines against tumor associated antigens Tn and Sialyl-Tn.

Authors:  F Hallouin; C Goupille; J Rocher; J Le Pendu
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

2.  Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors.

Authors:  Andreas A Hombach; Gunter Rappl; Hinrich Abken
Journal:  Mol Ther       Date:  2019-06-19       Impact factor: 11.454

3.  Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.

Authors:  S Ogata; R Koganty; M Reddish; B M Longenecker; A Chen; C Perez; S H Itzkowitz
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

4.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

5.  Enzymatic basis for sialyl-Tn expression in human colon cancer cells.

Authors:  I Brockhausen; J Yang; N Dickinson; S Ogata; S H Itzkowitz
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

6.  On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

Authors:  Govindaswami Ragupathi; Don M Coltart; Lawrence J Williams; Fusataka Koide; Ella Kagan; Jennifer Allen; Christina Harris; Peter W Glunz; Philip O Livingston; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

7.  Trefoil factor-3 expression in human colon cancer liver metastasis.

Authors:  Mark Babyatsky; Jing Lin; Xianyang Yio; Anli Chen; Jie-yu Zhang; Yan Zheng; Christina Twyman; Xiuliang Bao; Myron Schwartz; Swan Thung; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2008-11-02       Impact factor: 5.150

8.  A rat model to study the role of STn antigen in colon cancer.

Authors:  S Ogata; I Ho; J Maklansky; A Chen; J L Werther; M Reddish; B M Longenecker; E Sigurdson; S Iishi; J Y Zhang; S H Itzkowitz
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

9.  A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.

Authors:  Chengcheng Song; Xiu-Jing Zheng; Chang-Cheng Liu; Yifa Zhou; Xin-Shan Ye
Journal:  Oncotarget       Date:  2017-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.